Movement disorders in complex regional pain syndrome
Pain Medicine 2010; 11: 1274–1277Wiley Periodicals, Inc.Movement Disorders in Complex Regional Pain Syndromepme_9161274.1277 Jacobus J. van Hilten, MD, PhD Movement Disorders in CRPS: Neurological Entity or Psychogenic?
Department of Neurology, Leiden University MedicalCenter, Leiden, the Netherlands
In the field of movement disorders, several issues contrib-uted to a long-lasting ambiguity concerning the neurologi-cal or psychiatric origin of the MDs in CRPS. First, the
Reprint requests to: Jacobus J. van Hilten,
failure to demonstrate abnormalities in routine neurophysi-
Department of Neurology, Leiden University Medical
ological studies in CRPS type 1 patients with MDs [8].
Center, P.O. Box 9600, 2300 RC Leiden, the
Second, the concept that ultimately became dogma and
Netherlands. Tel: 31-71-5262895; Fax: 31-71-5248253;
related MDs like dystonia to dysfunction of the basal
ganglia-thalamocortical circuitry. Because in CRPS, MDsare frequently preceded by peripheral trauma, basalganglia involvement was neither demonstrated nor
Abstract
obvious from a clinical point of view. Consequently, MDsthat occurred in the absence of basal ganglia involvement
About 25% of the patients with complex regional
were for a long period considered non-organic. However,
pain syndrome (CRPS) suffer movement disorders,
a unique psychological profile was never demonstrated in
including loss of voluntary control, bradykinesia, dystonia, myoclonus, and tremor. These movement disorders are generally difficult to manage and add The Clinical Profile of MDs in CRPS considerably to the disease burden. Over the last years, interesting findings have emerged that show
The execution of voluntary movement in patients with
how tissue or nerve injury may induce spinal plas-
CRPS is commonly impaired, but these motor distur-
ticity (central sensitization), which alters sensory
bances frequently remain unnoticed or are attributed to
transmission and sensorimotor processing in the
the presence of pain. Loss of voluntary control is fre-
spinal cord and is associated with disinhibition.
quently experienced by patients suffering weakness or
These changes, in turn, set the stage for the devel-
dystonia. Typically, these patients report “My mind tells my
opment of movement disorders seen in CRPS. There
hand/foot to move, but it won’t work” [2]. This so-called
are no randomized control studies on the treatment
loss of voluntary control has been reported in other causes
of movement disorders in CRPS but findings from
of dystonia [11] and has been ascribed to both dysfunc-
fundamental and clinical research suggest that
tion of attention and abnormal sensorimotor integration
strategies that enhance the central inhibitory state may benefit these patients.
Bradykinesia or slowness of movement is very common in
Key Words. Complex Regional Pain Syndrome
CRPS patients and is evaluated by means of repetitive
(CRPS); Dystonia
finger or foot tapping. In CRPS patients, the performanceof these movements are typically slowed and frequently
Introduction
associated with hesitancies. Interestingly, patients withunilateral upper extremity CRPS, may also show bradyki-
Complex regional pain syndrome (CRPS) is characterized
nesia on the non-affected extremity [14].
by poorly controllable pain, swelling, and changes in skinblood flow and sweating that usually develop in the distal
Dystonia occurs in approximately 20% of patients with
extremities [1]. The syndrome is commonly preceded by a
CRPS and is characterized by fixed flexion postures of the
minor to severe trauma or surgical intervention [1]. There
fingers (Figure 1), wrist, and feet that may vary in severity
is compelling evidence that patients with CRPS may
[2,15]. In less affected patients without overt dystonia, this
develop movement disorders (MDs) including loss of vol-
may be provoked by repetitive tasks. Dystonia of the lower
untary control, bradykinesia, dystonia, myoclonus, and
extremity is usually characterized by inversion and/or
tremor. These MDs may occur early in the disease course
plantar flexion of the foot, with or without clawing or scis-
and occasionally precede the onset of the more typical
soring of the toes [2,15]. Dystonia may worsen by effort of
features of CRPS [2–4]. Findings from different studies
the involved extremity, under circumstances of cold tem-
indicate that 9–49% of the CRPS patients may develop
peratures and humidity, and in the more severely affected
MDs [2–5]. The prevalence of MDs increases as the
patients, by tactile and auditory stimuli. Contractures,
which frequently are also characterized by flexion postures
Movement Disorders in CRPS
central sensitization only involves pathways that deal withthe perception of pain and not those that mediate aresponse to pain. Indeed, two lines of research now showthat central sensitization may influence spinal motor cir-cuitry. First, findings from a recent study suggest that theinduction of central sensitization causes a spinal learningdeficit with respect to simple motor responses to shock[24]. Second, cutaneous afferents which mediate neuro-genic inflammation are also linked to spinal interneuronalcircuits that mediate nociceptive withdrawal reflexes(NWR) [25]. Animal models of neurogenic inflammationhave shown that SP released at the dorsal horn of the
Figure 1 Shows examples of upper and lower
spinal cord, enhances NWRs [26,27]. In withdrawalreflexes, flexor muscles play a prominent role, and inter-
extremity dystonia in CRPS patients.
estingly, in dystonia of CRPS there is a conspicuousinvolvement of flexor postures, which may hint towardsthe involvement of spinal motor programs that mediate
are a potential pitfall in diagnosing dystonia in CRPS. In
NWRs [15]. Neurophysiological studies have shown that
dystonia, however, passive stretching of affected digits
central disinhibition is a key characteristic of central
provokes a contraction of the stretched muscle sug-
nervous system involvement in CRPS patients with and
gesting stretch reflex hyperexcitability [16]. The interval
without dystonia [28–31]. Both SP-sensitized NWRs in
between the onset of CRPS and dystonia in the first
animal models and dystonia in CRPS patients respond to
affected extremity may vary from less than one week in
baclofen, a gamma-aminobutyric acid (GABA) B receptor
26% of the patients to more than one year in 25% of the
agonist which enhances spinal GABA-ergic inhibition on
patients [7]. Compared to CRPS patients without dysto-
neurons of the spinal cord [32,33]. Collectively, findings
nia, CRPS patients with dystonia have a younger age at
from different sources of research suggest that peripheral
onset and have an increased risk of spread of dystonia to
tissue or nerve injury may induce central sensitization,
other extremities [7]. Myoclonus (involuntary, brief, jerk-like
which is associated with spinal changes that may contrib-
contractions of a muscle or muscles) and tremor are fre-
quently reported by CRPS patients with dystonia butrarely may occur as the sole or predominant MD [14].
In CRPS, there is a conspicuous tendency for dystonia tospread to other extremities. In two studies, 37 and 67% of
MDs in CRPS: Mechanisms of Disease
the CRPS patients had two or more extremities affectedby dystonia [34,35]. Interestingly, the hazard of dystonia in
Compelling evidence suggests that in CRPS, different
subsequent extremities in patients with CRPS increases
mechanisms may play a role. Similarities between the
with the number of extremities already affected by dysto-
classical symptoms of inflammation and the clinical fea-
nia [7]. Apparently, once triggered, the underlying mecha-
tures of CRPS have led several investigators to suggest
nism of dystonia in CRPS has the capacity to facilitate the
that inflammation must play an important role in the syn-
occurrence of dystonia in other body parts. This accelle-
drome [17–19]. Tissue injury stimulates C and Ad-fibers of
rated disease course is a typical feature of maladaptive
sensory nerves, which causes the release of the inflam-
neuronal plasticity, as has been documented for pain [36].
matory neuropeptides substance P and Calcitonin-gene-
CRPS occurs more frequently in women (~75%). The
related-peptide from the afferent nerve endings [20].
gender imbalance is further increased in CRPS patients
These neuropeptides may induce local vasodilatation and
with dystonia (~85%) [2,7,35]. These findings may indicate
increased capillary permeability causing edema and an
that the female gender is a risk factor for clinical manifes-
increase of skin blood flow, a process known as neuro-
tations of maladaptive neuronal plasticity.
genic inflammation [20]. Indeed, several studies confirmedthat this mechanism is involved in the perturbed regulation
Although most evidence seems to indicate that dystonia in
of inflammation in CRPS [21,22]. Because neurogenic
CRPS occurs in the context of central sensitization in the
inflammation is initiated by sensory nerves, it remained
spinal cord, the question remains if supraspinal involve-
unclear how MDs may evolve in CRPS. However, nocice-
ment may contribute to the development of MDs in CRPS.
ptive neurons in the dorsal horns of the spinal cord may
Two functional magnetic resonance imaging (fMRI) studies
become sensitized (central sensitization) by peripheral
evaluated cerebral network function during the execution
tissue or nerve injury [23]. In central sensitization, there is
of voluntary movement in patients with CRPS with and
an increased sensitivity of spinal neurons, despite a lack of
without MDs [37,38]. One study that evaluated finger
change of afferent input. As a result, pain becomes
movements in CRPS patients without MDs revealed a
chronic and non-noxious stimuli become painful [23]. On a
significant reorganization of central motor circuits with
molecular level, central sensitization is associated with
increased activation of the primary motor cortex and
changes in the release of neuropeptides, neurotransmit-
supplementary motor cortices, and increased activation
ters, prostaglandine E2, and the expression of N-methyl
of the ipsilateral motor cortex [38]. Activity of the post-
aspartate receptors in particular [23]. It seems unlikely that
erior parietal cortices, supplementary motor cortices, and
van Hilten
primary motor cortex correlated with the degree of motor
6 Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs
dysfunction as assessed by the maximum finger tapping
and symptoms of reflex sympathetic dystrophy: Pro-
frequency. Another fMRI study on voluntary and imaginary
spective study of 829 patients. Lancet 1993;342:
hand movements in CRPS patients with dystonia showed
altered ipsilateral and contralateral cerebral activationduring imaginary movement of the dystonic hand [37].
7 van Rijn MA, Marinus J, Putter H, van Hilten JJ. Onset
Collectively, these studies provided important new insights
and progression of dystonia in complex regional pain
on the involvement of cortical circuitry in voluntary and
imaginary motor tasks in patients with CRPS. However, itremains unclear if these findings play a role in the MDs of
8 Verdugo RJ, Ochoa JL. Abnormal movements in
CRPS since Maihöfner et al. found that pain by itself is
complex regional pain syndrome: Assessment of their
sufficient to induce these cortical changes [38]. However,
nature. Muscle Nerve 2000;23:198–205.
given the important role of supraspinal sensorimotor net-works in the execution of movement, it is not unlikely thatsupraspinal changes may contribute to some of the clini-
9 Van der Laan L, van Spaendonck K, Horstink M, Goris
RJA. The symptom checklist-90 revised questionnaire:No psychological profiles in complex regional pain
MDs in CRPS: Treatment Options
syndrome–dystonia. J Pain Symptom Manage 1999;17:357–62.
There are no randomized controlled studies of physicaltherapy, occupational therapy, or oral pharmacotherapy in
10 Reedijk WB, van Rijn MA, Roelofs K, et al. Psychologi-
treatment of MDs in CRPS [39]. Splints or plaster casts are
cal features of patients with complex regional pain
often ineffective or may even worsen the dystonic postures
syndrome type I related dystonia. Mov Disord 2008;
of CRPS [39]. Benzodiazepines and high doses of
baclofen may be beneficial in the treatment of dystonia andspasms in patients with CRPS but the extent of improve-
11 Berardelli A, Rothwell JC, Hallett M, et al. The patho-
ment is rarely described. Also, no controlled studies exist
physiology of primary dystonia. Brain 1998;121:1195–
on the use of botulin toxin in dystonia in CRPS-I patients
[39]. One study reported on the beneficial effects of intrath-ecal baclofen therapy in a small number of patients withCRPS-I and dystonia [33]. However, given the complexity
12 Apkarian AV, Thomas PS, Krauss BR, Szeverenyi NM.
of this treatment, it should only be considered for patients
Prefrontal cortical hyperactivity in patients with sym-
with CRPS-I if dystonia is a major problem and conven-
pathetically mediated chronic pain. Neurosci Lett
tional therapy has proven ineffective [39]. References
13 Galer BS, Jensen M. Neglect-like symptoms in
1 Merskey H, Bogduk N. Complex regional pain syn-
complex regional pain syndrome: Results of a self-
drome, type I (Reflex sympathetic dystrophy. In:
administered survey. J Pain Symptom Manage 1999;
Merskey H, Bogduk N, eds. Classification of Chronic
Pain: Descriptions of Chronic Pain Syndromes andDefinitions of Pain Terms, 2nd edition. Seattle, WA:
14 van Hilten JJ, Blumberg H, Schwartzman RJ. Move-
ment disorders and dystrophy—Pathophysiology andmeasurement. In: Wilson P, Stanton-Hicks M, Harden
2 Schwartzman RJ, Kerrigan J. The movement disorder
N, eds. CRPS: Current Diagnosis and Therapies,
of reflex sympathetic dystrophy. Neurology 1990;40:
Progress in Pain Research and Management, Vol. 32.
3 Blumberg H, Jänig W. Clinical manifestations of
15 van Hilten JJ, van de Beek WJ, Vein AA, van Dijk JG,
reflex sympathetic dystrophy and sympathetically
Middelkoop HA. Clinical aspects of multifocal or gen-
maintained pain. In: Wall P, Melzack R, eds. Textbook
eralized tonic dystonia in reflex sympathetic dystrophy.
of Pain, 3rd edition. New York: Churchill Livingston;
4 Birklein F, Riedl B, Sieweke N, Weber M, Neundorfer
16 van de Beek WJT, Vein A, Hilgevoord AAJ, van Dijk
B. Neurological findings in complex regional pain syn-
JG, van Hilten JJ. Neurophysiological aspects of
dromes. Acta Neurol Scand 2000;101:262–9.
patients with generalized or multifocal dystonia inreflex sympathetic dystrophy. J Clin Neurophysiol
5 Harden RN, Bruehl S, Galer BS, et al. Complex
regional pain syndrome: Are the IASP diagnostic cri-teria valid and sufficiently comprehensive? Pain 1999;
17 Südeck P. Die sogenannte akute Knochenatrophie als
Entzündungsvorgang. Chirug 1942;15:449–57. Movement Disorders in CRPS
18 Oyen WJ, Arntz IE, Claessens RM, et al. Reflex
representation area in CRPS: A psychophysical and
sympathetic dystrophy of the hand: An excessive
transcranial magnetic stimulation study. Pain 2005;
inflammatory response? Pain 1993;55:151–7.
19 Van der Laan L, Goris RJ. Reflex sympathetic dystro-
30 Schwenkreis P, Janssen F, Rommel O, et al. Bilateral
phy. An exaggerated regional inflammatory response?
motor cortex disinhibition in complex regional pain
syndrome (CRPS) type I of the hand. Neurology2003;61:515–9.
20 Brain SD, Moore PK, eds. Pain and Neurogenic Inflam-
mation. Basel, Switzerland: Birkhauser Verlag; 1999.
31 Martino D, van de Warrenburg BP, Schneider SA,
et al. Cortical excitability is abnormal in patients withthe “fixed dystonia” syndrome. Mov Disord 2008;
21 Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R,
Fareed J. Role of neuropeptides in pathogenesis ofreflex sympathetic dystrophy. Acta Orthop Belg 1998;64:448–51.
32 Saito K, Konishi S, Otsuka M. Antagonism between
Lioresal and substance P in rat spinal cord. Brain Res1975;97:177–80.
22 Birklein F, Schmelz M, Schifter S, Weber M. The
important role of neuropeptides in complex regionalpain syndrome. Neurology 2001;26:2179–84.
33 van Hilten JJ, van de Beek WJT, Hoff JI, Voormolen
JH, Delhaas EM. Intrathecal baclofen for the treatmentof dystonia in patients with reflex sympathetic dystro-
23 Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology,
phy. N Engl J Med 2000;343:625–30.
symptoms, mechanisms, and management. Lancet1999;353:1959–64.
34 Schrag A, Trimble M, Quinn N, Bhatia K. The syn-
drome of fixed dystonia: An evaluation of 103 patients.
24 Ferguson AR, Crown ED, Grau JW. Nociceptive plas-
ticity inhibits adaptive learning in the spinal cord. Neuroscience 2006;141(1):421–31.
35 van der Laan L, van Spaendonck K, Horstink MW,
Goris RJ. The Symptom Checklist-90 Revised ques-
25 Floeter MK, Gerloff C, Kouri J, Hallett M. Cutaneous
withdrawal reflexes of the upper extremity. Muscle
regional pain syndrome-dystonia. J Pain Symptom
26 Parsons AM, Honda CN, Jiay P, et al. Spinal NK1
36 Woolf CJ, Salter MW. Neuronal plasticity: Increasing
receptors contribute to the increased excitability of the
the gain in pain. Science 2000;288:1765–9.
nociceptive flexor reflex during persistent peripheralinflammation. Brain Res 1996;739:263–75.
37 Gieteling EW, van Rijn MA, de Jong BM, et al. Jun 11.
Cerebral activation during motor imagery in complex
27 Woolf C, Wiesenfeld-Hallin Z. Substance P and calci-
regional pain syndrome type 1 with dystonia. Pain
tonin gene-related peptide synergistically modulate
the gain of the nociceptive flexor withdrawal reflex inthe rat. Neurosci Lett 1986;66:226–30.
38 Maihöfner C, Baron R, DeCol R, et al. The motor
system shows adaptive changes in complex regional
28 Krause P, Foerderreuther S, Straube A. Bilateral motor
pain syndrome. Brain 2007;130:2671–87.
cortex disinhibition in complex regional pain syndrome(CRPS) type I of the hand. Neurology 2003;61:515–9.
39 Geertzen JHB, Perez RSGM, Dijkstra PU, Kemper
MA, Rosenbrand CJGM. Evidence Based Guidelines
29 Eisenberg E, Chistyakov AV, Yudashkin M, et al. Evi-
for Complex Regional Pain. 2006. Available at: http://
dence for cortical hyperexcitability of the affected limb
pdver.atcomputing.nl/english.html (accessed 2006).
Roskydal® 500 A Reactive, unsaturated polyester (wax-free) which cures to yield hard films Form supplied In the formulation of clear and pigmented, wax-free coatings for wood andfurniture, high-gloss to matt, with good chemical resistance and very goodflow properties and scratch resistance. Also in the formulation of spray andcurtain-coating fillers for wood, metal and plastic. Specific
GI_Aciclovir_akut.qxp 22.09.2009 08:24 Seite 1 Gebrauchsinformation: Information für den Anwender Aciclovir akut Creme - 1A-Pharma® Wirkstoff: AciclovirLiebe Patientin, lieber Patient!Bitte lesen Sie die gesamte Packungsbeilage sorgfältig durch, denn Sie enthält wichtige Informationen für Sie. Dieses Arzneimittel ist ohne Verschreibung erhältlich. Um einen bestmöglichen Behandlung